Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
IT
Archived
•
November 14, 2025
•
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
Source: https://www.wired.com/feed/rss - Read Original
"Retirement Health Care"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
